Skip Navigation U.S. Department of Health and Human Services
Agency for Healthcare Research Quality
Archive print banner

Use of Behavioral Therapies for Treatment of Medical Disorders

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to for current information.

Part 1. Impact on Management of Patients with Diabetes Mellitus

Technology Assessment

The technology assessment program at the Agency for Healthcare Research and Quality (AHRQ) provides technology assessments for the Centers for Medicare & Medicaid Services (CMS). These technology assessments are used by CMS to inform its national coverage decisions for the Medicare program as well as provide information to Medicare carriers.

CMS, through AHRQ, requested the Duke Evidence-based Practice Center (EPC) to perform an evaluation of the evidence for the use of behavioral therapies for general medical disorders. This technology assessment focuses on diabetes mellitus.

Select to download the print version (PDF File, 680 KB). PDF Help.


   Appendix A: Description of Health and Behavior Assessment/Intervention CPT codes
   Appendix B: Search Strategies
   Appendix C: Key to Figures Illustrating Effect Size
   Appendix D: Evidence Tables

Prepared for AHRQ under Contract No. 290-02-0025. By David B. Matchar, M.D, Francis J. Keefe, Ph.D., Douglas C. McCrory, et al; Duke Evidence-based Practice Center, Center for Clinical Health Policy Research.

Current as of February 2004

The information on this page is archived and provided for reference purposes only.


AHRQ Advancing Excellence in Health Care